Compare MIN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIN | SOPH |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.2M | 330.4M |
| IPO Year | N/A | 2021 |
| Metric | MIN | SOPH |
|---|---|---|
| Price | $2.62 | $4.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 331.0K | 76.0K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 7.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | N/A | ★ $73,297,000.00 |
| Revenue This Year | N/A | $18.32 |
| Revenue Next Year | N/A | $15.61 |
| P/E Ratio | $33.38 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $2.52 | $2.58 |
| 52 Week High | $2.88 | $5.30 |
| Indicator | MIN | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 52.12 |
| Support Level | $2.59 | $4.50 |
| Resistance Level | $2.65 | $4.84 |
| Average True Range (ATR) | 0.03 | 0.22 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 43.75 | 48.00 |
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.